- Home
- CPHC vs SERA Comparison
CPHC vs SERA Comparison
Compare CPHC & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPHC | SERA |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 90.6M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CPHC | SERA |
|---|---|---|
| Price | $15.24 | $3.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.7K | ★ 42.6K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $59,099,604.00 | $95,000.00 |
| Revenue This Year | N/A | $19.22 |
| Revenue Next Year | N/A | $400.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.06 |
| 52 Week Low | $15.03 | $1.37 |
| 52 Week High | $22.93 | $9.13 |
Technical Indicators
Market Signals| Indicator | CPHC | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 60.54 |
| Support Level | $15.10 | $2.91 |
| Resistance Level | $15.49 | $3.14 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 44.44 | 79.55 |
Price Performance
Historical ComparisonAbout CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.